APA (7th ed.) Citation

H, J., M, R., RM, W., M, K., P, E., K, T., . . . F, R. (2021). KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer. Journal of personalized medicine, 11(6), . https://doi.org/10.3390/jpm11060473

Chicago Style (17th ed.) Citation

H, Jütte, et al. "KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer." Journal of Personalized Medicine 11, no. 6 (2021). https://doi.org/10.3390/jpm11060473.

MLA (9th ed.) Citation

H, Jütte, et al. "KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer." Journal of Personalized Medicine, vol. 11, no. 6, 2021, https://doi.org/10.3390/jpm11060473.